Global Hemostat Powder Market Growth 2025-2031

December 2024 | 122 pages | ID: G0647E35BCEEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Hemostat Powder market size is predicted to grow from US$ 413 million in 2025 to US$ 547 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Hemostat powder is product in form of powder.

Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.

North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.

Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.

LP Information, Inc. (LPI) ' newest research report, the “Hemostat Powder Industry Forecast” looks at past sales and reviews total world Hemostat Powder sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemostat Powder sales for 2025 through 2031. With Hemostat Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostat Powder industry.

This Insight Report provides a comprehensive analysis of the global Hemostat Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostat Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostat Powder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostat Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostat Powder.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemostat Powder market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Gelatin
  • Fibrin
  • Cellulose
  • Others
Segmentation by Application:
  • Surgical Wound Care
  • General Wound Care
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Johnson & Johnson
  • C. R. Bard
  • Pfizer
  • CSL Behring
  • Gelita Medical
  • Ferrosan Medical Devices
  • Baxter
  • Celox
  • Equimedical
  • Medira
  • Biocer
  • Hemostasis
  • MBP
Key Questions Addressed in this Report

What is the 10-year outlook for the global Hemostat Powder market?

What factors are driving Hemostat Powder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hemostat Powder market opportunities vary by end market size?

How does Hemostat Powder break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hemostat Powder Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Hemostat Powder by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Hemostat Powder by Country/Region, 2020, 2024 & 2031
2.2 Hemostat Powder Segment by Type
  2.2.1 Gelatin
  2.2.2 Fibrin
  2.2.3 Cellulose
  2.2.4 Others
2.3 Hemostat Powder Sales by Type
  2.3.1 Global Hemostat Powder Sales Market Share by Type (2020-2025)
  2.3.2 Global Hemostat Powder Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Hemostat Powder Sale Price by Type (2020-2025)
2.4 Hemostat Powder Segment by Application
  2.4.1 Surgical Wound Care
  2.4.2 General Wound Care
2.5 Hemostat Powder Sales by Application
  2.5.1 Global Hemostat Powder Sale Market Share by Application (2020-2025)
  2.5.2 Global Hemostat Powder Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Hemostat Powder Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Hemostat Powder Breakdown Data by Company
  3.1.1 Global Hemostat Powder Annual Sales by Company (2020-2025)
  3.1.2 Global Hemostat Powder Sales Market Share by Company (2020-2025)
3.2 Global Hemostat Powder Annual Revenue by Company (2020-2025)
  3.2.1 Global Hemostat Powder Revenue by Company (2020-2025)
  3.2.2 Global Hemostat Powder Revenue Market Share by Company (2020-2025)
3.3 Global Hemostat Powder Sale Price by Company
3.4 Key Manufacturers Hemostat Powder Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Hemostat Powder Product Location Distribution
  3.4.2 Players Hemostat Powder Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HEMOSTAT POWDER BY GEOGRAPHIC REGION

4.1 World Historic Hemostat Powder Market Size by Geographic Region (2020-2025)
  4.1.1 Global Hemostat Powder Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Hemostat Powder Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hemostat Powder Market Size by Country/Region (2020-2025)
  4.2.1 Global Hemostat Powder Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Hemostat Powder Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemostat Powder Sales Growth
4.4 APAC Hemostat Powder Sales Growth
4.5 Europe Hemostat Powder Sales Growth
4.6 Middle East & Africa Hemostat Powder Sales Growth

5 AMERICAS

5.1 Americas Hemostat Powder Sales by Country
  5.1.1 Americas Hemostat Powder Sales by Country (2020-2025)
  5.1.2 Americas Hemostat Powder Revenue by Country (2020-2025)
5.2 Americas Hemostat Powder Sales by Type (2020-2025)
5.3 Americas Hemostat Powder Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hemostat Powder Sales by Region
  6.1.1 APAC Hemostat Powder Sales by Region (2020-2025)
  6.1.2 APAC Hemostat Powder Revenue by Region (2020-2025)
6.2 APAC Hemostat Powder Sales by Type (2020-2025)
6.3 APAC Hemostat Powder Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Hemostat Powder by Country
  7.1.1 Europe Hemostat Powder Sales by Country (2020-2025)
  7.1.2 Europe Hemostat Powder Revenue by Country (2020-2025)
7.2 Europe Hemostat Powder Sales by Type (2020-2025)
7.3 Europe Hemostat Powder Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hemostat Powder by Country
  8.1.1 Middle East & Africa Hemostat Powder Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Hemostat Powder Revenue by Country (2020-2025)
8.2 Middle East & Africa Hemostat Powder Sales by Type (2020-2025)
8.3 Middle East & Africa Hemostat Powder Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostat Powder
10.3 Manufacturing Process Analysis of Hemostat Powder
10.4 Industry Chain Structure of Hemostat Powder

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Hemostat Powder Distributors
11.3 Hemostat Powder Customer

12 WORLD FORECAST REVIEW FOR HEMOSTAT POWDER BY GEOGRAPHIC REGION

12.1 Global Hemostat Powder Market Size Forecast by Region
  12.1.1 Global Hemostat Powder Forecast by Region (2026-2031)
  12.1.2 Global Hemostat Powder Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hemostat Powder Forecast by Type (2026-2031)
12.7 Global Hemostat Powder Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Hemostat Powder Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 C. R. Bard
  13.2.1 C. R. Bard Company Information
  13.2.2 C. R. Bard Hemostat Powder Product Portfolios and Specifications
  13.2.3 C. R. Bard Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 C. R. Bard Main Business Overview
  13.2.5 C. R. Bard Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Hemostat Powder Product Portfolios and Specifications
  13.3.3 Pfizer Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 CSL Behring
  13.4.1 CSL Behring Company Information
  13.4.2 CSL Behring Hemostat Powder Product Portfolios and Specifications
  13.4.3 CSL Behring Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 CSL Behring Main Business Overview
  13.4.5 CSL Behring Latest Developments
13.5 Gelita Medical
  13.5.1 Gelita Medical Company Information
  13.5.2 Gelita Medical Hemostat Powder Product Portfolios and Specifications
  13.5.3 Gelita Medical Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Gelita Medical Main Business Overview
  13.5.5 Gelita Medical Latest Developments
13.6 Ferrosan Medical Devices
  13.6.1 Ferrosan Medical Devices Company Information
  13.6.2 Ferrosan Medical Devices Hemostat Powder Product Portfolios and Specifications
  13.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Ferrosan Medical Devices Main Business Overview
  13.6.5 Ferrosan Medical Devices Latest Developments
13.7 Baxter
  13.7.1 Baxter Company Information
  13.7.2 Baxter Hemostat Powder Product Portfolios and Specifications
  13.7.3 Baxter Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Baxter Main Business Overview
  13.7.5 Baxter Latest Developments
13.8 Celox
  13.8.1 Celox Company Information
  13.8.2 Celox Hemostat Powder Product Portfolios and Specifications
  13.8.3 Celox Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Celox Main Business Overview
  13.8.5 Celox Latest Developments
13.9 Equimedical
  13.9.1 Equimedical Company Information
  13.9.2 Equimedical Hemostat Powder Product Portfolios and Specifications
  13.9.3 Equimedical Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Equimedical Main Business Overview
  13.9.5 Equimedical Latest Developments
13.10 Medira
  13.10.1 Medira Company Information
  13.10.2 Medira Hemostat Powder Product Portfolios and Specifications
  13.10.3 Medira Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Medira Main Business Overview
  13.10.5 Medira Latest Developments
13.11 Biocer
  13.11.1 Biocer Company Information
  13.11.2 Biocer Hemostat Powder Product Portfolios and Specifications
  13.11.3 Biocer Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Biocer Main Business Overview
  13.11.5 Biocer Latest Developments
13.12 Hemostasis
  13.12.1 Hemostasis Company Information
  13.12.2 Hemostasis Hemostat Powder Product Portfolios and Specifications
  13.12.3 Hemostasis Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Hemostasis Main Business Overview
  13.12.5 Hemostasis Latest Developments
13.13 MBP
  13.13.1 MBP Company Information
  13.13.2 MBP Hemostat Powder Product Portfolios and Specifications
  13.13.3 MBP Hemostat Powder Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 MBP Main Business Overview
  13.13.5 MBP Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Hemostat Powder Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hemostat Powder Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gelatin
Table 4. Major Players ofFibrin
Table 5. Major Players of Cellulose
Table 6. Major Players of Others
Table 7. Global Hemostat Powder Sales byType (2020-2025) & (K MT)
Table 8. Global Hemostat Powder Sales Market Share byType (2020-2025)
Table 9. Global Hemostat Powder Revenue byType (2020-2025) & ($ million)
Table 10. Global Hemostat Powder Revenue Market Share byType (2020-2025)
Table 11. Global Hemostat Powder Sale Price byType (2020-2025) & (USD/MT)
Table 12. Global Hemostat Powder Sale by Application (2020-2025) & (K MT)
Table 13. Global Hemostat Powder Sale Market Share by Application (2020-2025)
Table 14. Global Hemostat Powder Revenue by Application (2020-2025) & ($ million)
Table 15. Global Hemostat Powder Revenue Market Share by Application (2020-2025)
Table 16. Global Hemostat Powder Sale Price by Application (2020-2025) & (USD/MT)
Table 17. Global Hemostat Powder Sales by Company (2020-2025) & (K MT)
Table 18. Global Hemostat Powder Sales Market Share by Company (2020-2025)
Table 19. Global Hemostat Powder Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Hemostat Powder Revenue Market Share by Company (2020-2025)
Table 21. Global Hemostat Powder Sale Price by Company (2020-2025) & (USD/MT)
Table 22. Key Manufacturers Hemostat Powder Producing Area Distribution and Sales Area
Table 23. Players Hemostat Powder Products Offered
Table 24. Hemostat Powder Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Hemostat Powder Sales by Geographic Region (2020-2025) & (K MT)
Table 28. Global Hemostat Powder Sales Market Share Geographic Region (2020-2025)
Table 29. Global Hemostat Powder Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Hemostat Powder Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Hemostat Powder Sales by Country/Region (2020-2025) & (K MT)
Table 32. Global Hemostat Powder Sales Market Share by Country/Region (2020-2025)
Table 33. Global Hemostat Powder Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Hemostat Powder Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Hemostat Powder Sales by Country (2020-2025) & (K MT)
Table 36. Americas Hemostat Powder Sales Market Share by Country (2020-2025)
Table 37. Americas Hemostat Powder Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Hemostat Powder Sales byType (2020-2025) & (K MT)
Table 39. Americas Hemostat Powder Sales by Application (2020-2025) & (K MT)
Table 40. APAC Hemostat Powder Sales by Region (2020-2025) & (K MT)
Table 41. APAC Hemostat Powder Sales Market Share by Region (2020-2025)
Table 42. APAC Hemostat Powder Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Hemostat Powder Sales byType (2020-2025) & (K MT)
Table 44. APAC Hemostat Powder Sales by Application (2020-2025) & (K MT)
Table 45. Europe Hemostat Powder Sales by Country (2020-2025) & (K MT)
Table 46. Europe Hemostat Powder Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Hemostat Powder Sales byType (2020-2025) & (K MT)
Table 48. Europe Hemostat Powder Sales by Application (2020-2025) & (K MT)
Table 49. Middle East & Africa Hemostat Powder Sales by Country (2020-2025) & (K MT)
Table 50. Middle East & Africa Hemostat Powder Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Hemostat Powder Sales byType (2020-2025) & (K MT)
Table 52. Middle East & Africa Hemostat Powder Sales by Application (2020-2025) & (K MT)
Table 53. Key Market Drivers & Growth Opportunities of Hemostat Powder
Table 54. Key Market Challenges & Risks of Hemostat Powder
Table 55. Key IndustryTrends of Hemostat Powder
Table 56. Hemostat Powder Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Hemostat Powder Distributors List
Table 59. Hemostat Powder Customer List
Table 60. Global Hemostat Powder SalesForecast by Region (2026-2031) & (K MT)
Table 61. Global Hemostat Powder RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Hemostat Powder SalesForecast by Country (2026-2031) & (K MT)
Table 63. Americas Hemostat Powder Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Hemostat Powder SalesForecast by Region (2026-2031) & (K MT)
Table 65. APAC Hemostat Powder Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Hemostat Powder SalesForecast by Country (2026-2031) & (K MT)
Table 67. Europe Hemostat Powder RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Hemostat Powder SalesForecast by Country (2026-2031) & (K MT)
Table 69. Middle East & Africa Hemostat Powder RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Hemostat Powder SalesForecast byType (2026-2031) & (K MT)
Table 71. Global Hemostat Powder RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Hemostat Powder SalesForecast by Application (2026-2031) & (K MT)
Table 73. Global Hemostat Powder RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Johnson & Johnson Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Hemostat Powder Product Portfolios and Specifications
Table 76. Johnson & Johnson Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. C. R. Bard Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 80. C. R. Bard Hemostat Powder Product Portfolios and Specifications
Table 81. C. R. Bard Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. C. R. Bard Main Business
Table 83. C. R. Bard Latest Developments
Table 84. Pfizer Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Hemostat Powder Product Portfolios and Specifications
Table 86. Pfizer Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. CSL Behring Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Behring Hemostat Powder Product Portfolios and Specifications
Table 91. CSL Behring Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. CSL Behring Main Business
Table 93. CSL Behring Latest Developments
Table 94. Gelita Medical Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 95. Gelita Medical Hemostat Powder Product Portfolios and Specifications
Table 96. Gelita Medical Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Gelita Medical Main Business
Table 98. Gelita Medical Latest Developments
Table 99.Ferrosan Medical Devices Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 100.Ferrosan Medical Devices Hemostat Powder Product Portfolios and Specifications
Table 101.Ferrosan Medical Devices Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102.Ferrosan Medical Devices Main Business
Table 103.Ferrosan Medical Devices Latest Developments
Table 104. Baxter Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 105. Baxter Hemostat Powder Product Portfolios and Specifications
Table 106. Baxter Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Baxter Main Business
Table 108. Baxter Latest Developments
Table 109. Celox Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 110. Celox Hemostat Powder Product Portfolios and Specifications
Table 111. Celox Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Celox Main Business
Table 113. Celox Latest Developments
Table 114. Equimedical Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 115. Equimedical Hemostat Powder Product Portfolios and Specifications
Table 116. Equimedical Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Equimedical Main Business
Table 118. Equimedical Latest Developments
Table 119. Medira Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 120. Medira Hemostat Powder Product Portfolios and Specifications
Table 121. Medira Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Medira Main Business
Table 123. Medira Latest Developments
Table 124. Biocer Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 125. Biocer Hemostat Powder Product Portfolios and Specifications
Table 126. Biocer Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biocer Main Business
Table 128. Biocer Latest Developments
Table 129. Hemostasis Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 130. Hemostasis Hemostat Powder Product Portfolios and Specifications
Table 131. Hemostasis Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Hemostasis Main Business
Table 133. Hemostasis Latest Developments
Table 134. MBP Basic Information, Hemostat Powder Manufacturing Base, Sales Area and Its Competitors
Table 135. MBP Hemostat Powder Product Portfolios and Specifications
Table 136. MBP Hemostat Powder Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. MBP Main Business
Table 138. MBP Latest Developments



LIST OFFIGURES

Figure 1. Picture of Hemostat Powder
Figure 2. Hemostat Powder Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostat Powder Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Hemostat Powder Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hemostat Powder Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hemostat Powder Sales Market Share by Country/Region (2024)
Figure 10. Hemostat Powder Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Gelatin
Figure 12. Product Picture ofFibrin
Figure 13. Product Picture of Cellulose
Figure 14. Product Picture of Others
Figure 15. Global Hemostat Powder Sales Market Share byType in 2025
Figure 16. Global Hemostat Powder Revenue Market Share byType (2020-2025)
Figure 17. Hemostat Powder Consumed in Surgical Wound Care
Figure 18. Global Hemostat Powder Market: Surgical Wound Care (2020-2025) & (K MT)
Figure 19. Hemostat Powder Consumed in General Wound Care
Figure 20. Global Hemostat Powder Market: General Wound Care (2020-2025) & (K MT)
Figure 21. Global Hemostat Powder Sale Market Share by Application (2024)
Figure 22. Global Hemostat Powder Revenue Market Share by Application in 2025
Figure 23. Hemostat Powder Sales by Company in 2025 (K MT)
Figure 24. Global Hemostat Powder Sales Market Share by Company in 2025
Figure 25. Hemostat Powder Revenue by Company in 2025 ($ millions)
Figure 26. Global Hemostat Powder Revenue Market Share by Company in 2025
Figure 27. Global Hemostat Powder Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Hemostat Powder Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Hemostat Powder Sales 2020-2025 (K MT)
Figure 30. Americas Hemostat Powder Revenue 2020-2025 ($ millions)
Figure 31. APAC Hemostat Powder Sales 2020-2025 (K MT)
Figure 32. APAC Hemostat Powder Revenue 2020-2025 ($ millions)
Figure 33. Europe Hemostat Powder Sales 2020-2025 (K MT)
Figure 34. Europe Hemostat Powder Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Hemostat Powder Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Hemostat Powder Revenue 2020-2025 ($ millions)
Figure 37. Americas Hemostat Powder Sales Market Share by Country in 2025
Figure 38. Americas Hemostat Powder Revenue Market Share by Country (2020-2025)
Figure 39. Americas Hemostat Powder Sales Market Share byType (2020-2025)
Figure 40. Americas Hemostat Powder Sales Market Share by Application (2020-2025)
Figure 41. United States Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Hemostat Powder Sales Market Share by Region in 2025
Figure 46. APAC Hemostat Powder Revenue Market Share by Region (2020-2025)
Figure 47. APAC Hemostat Powder Sales Market Share byType (2020-2025)
Figure 48. APAC Hemostat Powder Sales Market Share by Application (2020-2025)
Figure 49. China Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 53. India Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Hemostat Powder Sales Market Share by Country in 2025
Figure 57. Europe Hemostat Powder Revenue Market Share by Country (2020-2025)
Figure 58. Europe Hemostat Powder Sales Market Share byType (2020-2025)
Figure 59. Europe Hemostat Powder Sales Market Share by Application (2020-2025)
Figure 60. Germany Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 61.France Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Hemostat Powder Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Hemostat Powder Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Hemostat Powder Sales Market Share by Application (2020-2025)
Figure 68. Egypt Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Hemostat Powder Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Hemostat Powder in 2025
Figure 74. Manufacturing Process Analysis of Hemostat Powder
Figure 75. Industry Chain Structure of Hemostat Powder
Figure 76. Channels of Distribution
Figure 77. Global Hemostat Powder Sales MarketForecast by Region (2026-2031)
Figure 78. Global Hemostat Powder Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Hemostat Powder Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Hemostat Powder Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Hemostat Powder Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Hemostat Powder Revenue Market ShareForecast by Application (2026-2031)